Dragonfly Therapeutics
Blood & Organ Banks · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
35 Gatehouse Dr, Waltham, Massachusetts,...Phone Number
(617) 588-0086Website
www.dragonflytx.comRevenue
$8.4 MillionIndustry
About Dragonfly Therapeutics
Dragonfly Therapeutics, Inc. is focused on revolutionizing disease treatment through the development of advanced immunotherapies aimed at improving patient outcomes. The company has established a broad pipeline of novel B & T cell depleters targeting critical autoimmune diseases, oncology, fibrosis, and neuro-inflammation. Collaborating with major pharmaceutical partners like AbbVie, BMS, and Gilead, Dragonfly rapidly develops drugs to address high unmet medical needs. Their innovative approach includes creating novel immune engagers across various therapeutic areas.Explore more
Dragonfly Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Dragonfly Therapeutics
Compare insights from companies similar to Dragonfly Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dragonfly Therapeutics Tech Stack
A closer look at the technologies used by Dragonfly Therapeutics
See more technologies
Top Blood & Organ Banks Companies
Frequently Asked Questions Regarding Dragonfly Therapeutics
Sign Up For FreeTo access detailed company insights
Dragonfly Therapeutics, Inc. is focused on revolutionizing disease treatment through the development of advanced immunotherapies aimed at improving patient outcomes. The company has established a broad pipeline of novel B & T cell depleters targeting critical autoimmune diseases, oncology, fibrosis, and neuro-inflammation. Collaborating with major... Read More
